rss
Tob Control 2000;9:ii1 doi:10.1136/tc.9.suppl_2.ii1
  • Foreword

  1. JEROME BECK,
  2. JEFFREY CHEEK,
  3. PHILLIP GARDINER,
  4. SUSANNE HILDEBRAND-ZANKI
  1. Tobacco Related Disease Research Program
  2. Office of Health Affairs
  3. University of California, Office of the President
  4. 300 Lakeside Drive, 6th Floor
  5. Oakland, California 94612-3550, USA

      As we enter the 21st century, tobacco researchers and tobacco control advocates, along with the Tobacco Related Disease Research Program (TRDRP), are coming to grips with the sobering reality that tobacco use, especially cigarette smoking, continues as a growing global epidemic. With 1.1 billion smokers worldwide, and the tobacco industry successfully recruiting new smokers every day, tobacco related disease will increase as the century progresses. The World Health Organization estimates that 80% of tobacco related deaths will take place in poorer nations, particularly countries in Africa, Asia, and Latin America. This situation desperately cries out for not only increased tobacco control efforts, but also amplified research programs to develop innovative, effective treatments for nicotine dependence and tobacco-related disease as well as new approaches to reduce tobacco use. In this regard, TRDRP is hopeful that US state governments, …

      Register for free content

      The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register hereto access the free archive of all BMJ Journals.

      Don't forget to sign up for content alertsso you keep up to date with all the articles as they are published.